Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have spe…
Biotechnology
US, Boston [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Vertex Pharmaceuticals Incorporated (VRTX) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 36,063.95 | 14,145.92 | 748.45 | 92.14 | -1,131.27 | 0.00 | 12.8201 | 47.76 | -0.0641 | -19.6086 | -0.08 | -0.10 | 7.0040 | - - | ||
| Maximum | - - | - - | - - | 1,535,067.00 | 609,984.00 | 35,800.00 | 99,050.00 | 5,421.00 | 0.02 | 701.8537 | 2,849.43 | 3.0051 | 85.3485 | 0.15 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -6,783.00 | -56,335.00 | -50,658.00 | 0.00 | -164.8536 | -57.22 | -16.7400 | -1,444.7800 | -1.56 | -12.64 | 0.0844 | - - | ||
| Seagen Inc. SGEN | 228.74 | -0.16 -0.07% | 19,392 vs. 1,634 | 43,154.00 | 648.00 | -215.00 | -79.00 | -2,756.00 | -1.1500 | -46.2406 | 0.0000 | 0.7452 | -0.3327 | -0.0846 | -0.0594 | 1.9572 | 188.00 | ||
| Moderna, Inc. MRNA | 38.25 | 1.31 3.55% | 8,876 vs. 6,491 | 14,719.00 | 167.00 | -1,175.00 | -1,185.00 | 12,431.00 | -3.0800 | -8.5828 | 0.0000 | 0.2096 | -7.0359 | -0.0917 | -0.0702 | 3.7508 | 384.00 | ||
| Madrigal Pharmaceuticals, Inc. MDGL | 329.24 | 12.15 3.83% | 421 vs. 376 | 7,180.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.0000 | 0.0000 | 0.0000 | -0.1734 | -0.1363 | 9.2623 | 21.00 | ||
| Vertex Pharmaceuticals Incorporated VRTX | 450.37 | -0.86 -0.19% | 1,492 vs. 1,118 | 115,983.00 | 2,687.00 | 1,099.00 | 1,058.00 | 11,242.00 | 4.2600 | 24.6835 | 0.0000 | 0.8725 | 0.4092 | 0.0593 | 0.0460 | 3.1520 | 257.00 | ||
| Regeneron Pharmaceuticals, Inc. REGN | 744.50 | 1.15 0.15% | 971 vs. 693 | 80,459.00 | 3,145.00 | 722.00 | 1,350.00 | 27,982.00 | 6.7000 | 36.1813 | 0.0000 | 0.8258 | 0.2296 | 0.0267 | 0.0210 | 4.3960 | 108.00 | ||
| Krystal Biotech, Inc. KRYS | 182.29 | 4.19 2.35% | 185 vs. 225 | 5,242.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.0000 | 0.9465 | 0.0206 | 0.0012 | 0.0011 | 12.2870 | 28.00 | ||
| Intellia Therapeutics, Inc. NTLA | 13.80 | 0.68 5.18% | 3,520 vs. 2,168 | 1,405.00 | 28.00 | -107.00 | -123.00 | -1,765.00 | -1.1200 | -6.0491 | 0.0000 | 0.9132 | -3.7130 | -0.1037 | -0.0853 | 8.4537 | 101.00 | ||
| CRISPR Therapeutics AG CRSP | 46.29 | -0.97 -2.05% | 2,088 vs. 1,262 | 3,951.00 | 0.00 | -116.00 | 109.00 | -1,116.00 | -1.4300 | -11.9580 | 0.0000 | -101.7758 | -231.3313 | -0.0559 | -0.0478 | 17.7168 | 85.00 | ||
| Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.0000 | 0.9628 | 8.4849 | 2.2110 | 0.3840 | 2.8209 | 38.00 | ||
| BioMarin Pharmaceutical Inc. BMRN | 63.45 | 0.89 1.42% | 1,230 vs. 1,774 | 12,092.00 | 648.00 | 88.00 | 12.00 | -532.00 | 0.4700 | 46.3847 | 0.0000 | 0.7850 | 0.1366 | 0.0175 | 0.0129 | 1.5477 | 190.00 | ||
| Alnylam Pharmaceuticals, Inc. ALNY | 246.80 | -1.99 -0.80% | 676 vs. 859 | 31,832.00 | 494.00 | -65.00 | -94.00 | -7,075.00 | -0.5200 | -73.3326 | 0.0000 | 0.8665 | -0.1334 | 0.3007 | -0.0172 | 2.8593 | 128.00 | ||
| Sarepta Therapeutics, Inc. SRPT | 110.50 | -0.36 -0.32% | 909 vs. 864 | 10,554.00 | 413.00 | 36.00 | -284.00 | -4,410.00 | 0.3800 | 83.5325 | 0.0000 | 0.8777 | 0.0874 | 0.0376 | 0.0112 | 2.9737 | 95.00 | ||
| PTC Therapeutics, Inc. PTCT | 42.89 | 0.93 2.22% | 581 vs. 714 | 3,307.00 | 210.00 | -91.00 | 6.00 | -3,375.00 | -1.2000 | -5.9705 | 0.0000 | 0.6846 | -0.4358 | 0.1024 | -0.0512 | 1.8854 | 77.00 | ||
| Beam Therapeutics Inc. BEAM | 23.58 | -0.91 -3.72% | 1,009 vs. 960 | 1,952.00 | 7.00 | -98.00 | -102.00 | -1,288.00 | -1.2100 | -6.7607 | 0.0000 | 0.2671 | -13.3157 | -0.1080 | -0.0726 | 5.8464 | 82.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.